We are live on ! Find out more
LPC

Lion Point Capital Portfolio holdings

AUM $16.7M
1-Year Est. Return 119.35%
This Fund
S&P 500
This Quarter Est. Return
+15.04%
1 Year Est. Return
+119.35%
3 Year Est. Return
+204.43%
5 Year Est. Return
+220.32%
10 Year Est. Return
+1,396.08%
AUM
$221M
AUM Growth
-$21.6M
Cap. Flow
-$49.7M
Cap. Flow %
-22.47%
Top 10 Hldgs %
93.3%
Holding
38
New
7
Increased
5
Reduced
8
Closed
8

Top Buys

Rank Stock Value
1
BLUE
bluebird bio
BLUE
+$1.94M
2
FENC icon
Fennec Pharmaceuticals
FENC
+$915K
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$781K
4
SNDX icon
Syndax Pharmaceuticals
SNDX
+$718K
5
WHWK
Whitehawk Therapeutics
WHWK
+$641K

Top Sells

Rank Stock Value
1
ARNC
Arconic Corporation
ARNC
+$18.7M
2
CHRD icon
Chord Energy
CHRD
+$15.8M
3
PDCE
PDC Energy, Inc.
PDCE
+$8.8M
4
CIVI
Civitas Resources
CIVI
+$4.44M
5
DRRX
DURECT Corp
DRRX
+$4.19M

Sector Composition

Rank Sector Weight
1 Technology 28.23%
2 Healthcare 11.32%
3 Energy 8.1%
4 Consumer Discretionary 1.95%
5 Materials 0.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BFIIW
26
CALL
DELISTED
BurgerFi International, Inc. Warrant
BFIIW
$266K 0.12%
2,083,438
– –
LUMO
27
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$259K 0.12%
78,351
+27,146
+53% +$95.8K
MSFT icon
28
Microsoft
MSFT
$2.92T
$34.1K 0.02%
100
– –
GOOG icon
29
Alphabet (Google) Class C
GOOG
$4.07T
$12.1K 0.01%
100
– –
PDCE
30
DELISTED
PDC Energy, Inc.
PDCE
$7.11K ﹤0.01%
100
-130,298
-100% -$8.8M
CIVI
31
DELISTED
Civitas Resources
CIVI
– –
-65,000
Closed -$4.44M
DNTH icon
32
Dianthus Therapeutics
DNTH
$5.55B
– –
-284,904
Closed -$3.62M
MRSN
33
DELISTED
Mersana Therapeutics
MRSN
– –
-16,365
Closed -$2.39M
ARNC
34
DELISTED
Arconic Corporation
ARNC
– –
-712,358
Closed -$18.7M
BLU
35
DELISTED
BELLUS Health Inc.
BLU
– –
-45,000
Closed -$324K
STSA
36
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
– –
-319,742
Closed -$223K
SDIG
37
DELISTED
Stronghold Digital Mining, Inc. Class A Common Stock
SDIG
– –
-2,000
Closed -$12.4K
CTIC
38
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
– –
-601,579
Closed -$2.53M
1
2

Similar funds

PA
PPM America Chicago, Illinois $16.6M AUM 31.99% 1-Year Est. Return
SR
Swiss Re Zurich, Switzerland $16.4M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
SRA
Summit Rock Advisors New York $16M AUM
CP
Covalent Partners Concord, Massachusetts $17.6M AUM 2.91% 1-Year Est. Return
B
BP London, United Kingdom $17.7M AUM 12.34% 1-Year Est. Return
CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
BCPE
Bain Capital Public Equity Boston, Massachusetts $18M AUM 35.19% 1-Year Est. Return

Lion Point Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Lion Point Capital held 38 positions worth $221M, down 8.9% from $243M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Lion Point Capital withdrew a net $49.7M in Q2 2023, closing 8 positions and reducing 8 holdings. Its most notable exit was Arconic Corporation, an estimated $18.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 24% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Lion Point Capital opened a new position in bluebird bio worth $1.75M.

  • Lion Point Capital's largest Q2 2023 buy was bluebird bio: 26,563 shares worth $1.75M.
  • Lion Point Capital added most to Seres Therapeutics in Q2 2023, an estimated $517K increase.
  • Lion Point Capital's biggest Q2 2023 reduction was Chord Energy, cutting an estimated $15.8M.
  • Lion Point Capital fully exited Arconic Corporation in Q2 2023, selling an estimated $18.7M.
  • Lion Point Capital's ten largest holdings make up 93% of its $221M portfolio in Q2 2023.
  • Lion Point Capital opened 7 new positions and closed 8 in Q2 2023.
  • Lion Point Capital's portfolio value fell 8.9% quarter-over-quarter to $221M.

Based on Lion Point Capital's 13F filing for Q2 2023, filed 14 Aug 2023.